Jubilant Pharmova Ashish Mukkirwar Appointed as New Chief Financial Officer
Jubilant Pharmova Limited has announced a leadership transition in its finance department. Mr. Arun Kumar Sharma has relinquished his role as…
3M India Limited Strong Growth and Dividend Recommendation for Financial Year 2026
3M India Limited has announced its financial results for the quarter and year ended March 31, 2026, reporting a robust 14.5% annual revenue…
Jubilant Pharmova Board Approves Re-appointment of Managing Director and Joint Managing Director
Jubilant Pharmova has announced the board-approved re-appointment of its top leadership team. Mr. Priyavrat Bhartia continues as the Managing…
Jubilant Pharmova Leadership Transition in Finance Department
Jubilant Pharmova has announced a key leadership transition within its finance department. Mr. Arun Kumar Sharma will step down as Chief…
KIMS Hospitals Reports Stable Growth in Q4 FY26 Amid Strategic Expansion
Krishna Institute of Medical Sciences (KIMS) Hospitals reported a stable performance for Q4 FY26, with total revenue reaching INR 1,084 crore,…
3M India Limited Announces Annual Financial Results and Dividend Recommendation
3M India Limited has reported strong financial results for the fiscal year ending March 31, 2026. The company achieved a 14.5% annual sales…
Computer Age Management Services Limited Annual Secretarial Compliance Report Released
Computer Age Management Services Limited (CAMS) has released its Annual Secretarial Compliance Report for the financial year ended March 31,…
Jubilant Pharmova Annual Audited Financial Results and Final Dividend Recommendation
Jubilant Pharmova has released its audited financial results for the quarter and financial year ended March 31, 2026. The company reported a…
Electronics Mart India Limited Reports Robust Financial Growth for FY26
Electronics Mart India Limited (EMIL) has announced its financial results for the fourth quarter and the full fiscal year ended March 31,…
Jubilant Pharmova Audited Financial Results and Dividend Announcement for FY 2026
Jubilant Pharmova Limited has reported a strong performance for the financial year ended March 31, 2026. The company achieved consolidated…